mrna moderna - Search News

Moderna, Trump and bird flu

Trump Officials Review Biden-Era Funding For Moderna Bird Flu Vaccine Contract

US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days of the Biden administration. The evaluation is part of a broader effort to reassess spending on mRNA-based vaccines,

Reuters · 1d

Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

The Hill on MSN · 23h

HHS weighs rescinding Moderna bird flu vaccine contract

The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in the waning days of the Biden administration. “While it is crucial

Hosted on MSN6h

Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?

Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock ...

10h

UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

RESVIA ®is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 /Moderna, Inc.

Moderna receives MHRA marketing authorization for RSV vaccine

Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for ...

BioSpace15hOpinion

Opinion: How mRNA Can Help Bridge the Innovation Gap in Rare Disease

As it did during the COVID-19 pandemic, mRNA technology offers an efficient way forward in developing products for diseases ...

Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

9don MSN

Why Moderna (MRNA) Went Up on Tuesday?

We recently published a list of 10 Firms Kick Off Shortened Trading Week With Impressive Gains. In this article, we are going ...

Moderna to Present at Upcoming Conferences in March 2025

Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...

Moderna, Inc.: Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...

2don MSN

Moderna, Inc. (MRNA): A Bull Case Theory

We came across a bullish thesis on Moderna, Inc. (MRNA) on wallstreetbets Subreddit Page by YouAlwaysHaveAChoice. In this ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results